Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Paus

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Cancer Letters|June 30, 1990
Neuron specific enolase (NSE) in serum of patients with malignant melanomaE Wibe, E Paus, S Aamdal
Scandinavian Journal of Psychology|January 1, 1973
Effect of task, selection set, and dispersion of attention on visual identification timeP Schioldborg, E Paus, G Myhre
The Journal of Urology|December 1, 1990
Flutamide in hormone-resistant prostatic cancerS D Fosså, G Hosbach, E Paus
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1991
Tumour markers as seen from the clinical laboratory: physiological, biochemical, and analytical aspectsO P Børmer, E Paus, K Nustad
British Journal of Cancer|July 1, 1992
The prognostic significance of prostate specific antigen in metastatic hormone-resistant prostate cancerS D Fosså, H Waehre, E Paus
British Journal of Cancer|February 1, 1992
Neuron-specific enolase--a serum tumour marker in seminoma?S D Fosså, O Klepp, E Paus
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 11, 2000
Epitope mapping and affinity estimation of 83 antibodies against prostate-specific antigenE Paus, K Nustad, O P Børmer
Clinical Chemistry|April 28, 2001
Development of a rapid and sensitive immunofluorometric assay for glutathione S-transferase AL K Dajani, E Paus, D J Warren
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Neuron-specific enolase as a prognostic factor in metastatic malignant melanomaE Wibe, E Hannisdal, E Paus, et al.
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1985
Intramuscular administration of hydroxyprogesterone caproate in patients with endometrial carcinoma. Pharmacokinetics and effects on adrenal functionM Onsrud, E Paus, E Haug, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Cancer Letters|June 30, 1990
Neuron specific enolase (NSE) in serum of patients with malignant melanomaE Wibe, E Paus, S Aamdal
Scandinavian Journal of Psychology|January 1, 1973
Effect of task, selection set, and dispersion of attention on visual identification timeP Schioldborg, E Paus, G Myhre
The Journal of Urology|December 1, 1990
Flutamide in hormone-resistant prostatic cancerS D Fosså, G Hosbach, E Paus
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1991
Tumour markers as seen from the clinical laboratory: physiological, biochemical, and analytical aspectsO P Børmer, E Paus, K Nustad
British Journal of Cancer|July 1, 1992
The prognostic significance of prostate specific antigen in metastatic hormone-resistant prostate cancerS D Fosså, H Waehre, E Paus
British Journal of Cancer|February 1, 1992
Neuron-specific enolase--a serum tumour marker in seminoma?S D Fosså, O Klepp, E Paus
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 11, 2000
Epitope mapping and affinity estimation of 83 antibodies against prostate-specific antigenE Paus, K Nustad, O P Børmer
Clinical Chemistry|April 28, 2001
Development of a rapid and sensitive immunofluorometric assay for glutathione S-transferase AL K Dajani, E Paus, D J Warren
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Neuron-specific enolase as a prognostic factor in metastatic malignant melanomaE Wibe, E Hannisdal, E Paus, et al.
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1985
Intramuscular administration of hydroxyprogesterone caproate in patients with endometrial carcinoma. Pharmacokinetics and effects on adrenal functionM Onsrud, E Paus, E Haug, et al.
Pageof 7